Related by context. Frequent words. (Click for all words.) 68 sodium Injection 65 Genasense R oblimersen 64 include LibiGel ® 61 FQ = fiscal 59 Argatroban 59 DNA RNA Medicines 56 Omigard 56 ZALBIN 56 VANTAS 56 Shigamabs R 55 BLA submission 55 PROPEL trial 55 Ixempra 55 Investigational Device Exemption 55 Rotarix R 55 vernakalant iv 54 BioMarin Genzyme LLC 54 ANDA approvals 54 Files Shelf Registration Statement 54 SILENOR TM 54 Visudyne R 54 Investigational Device Exemption IDE 54 Elevess 53 Icatibant 53 Entereg R 53 refractory chronic lymphocytic 53 IND Investigational New 53 Rosetta dependence 53 Drug Submission 52 NEBIDO 52 Including discontinued operations 52 alvimopan 52 MOZOBIL 52 Soliris TM eculizumab 52 MONOVISC 52 Onsolis 52 ZEGERID Capsules 52 Application BLA 52 Vitaros 52 liprotamase 52 dirucotide 52 apaziquone 52 exemption IDE 52 Loramyc R 51 IND submission 51 TranSwitch indebtedness 51 Exelbine 51 Clinical Trial Application 51 Eligard R 51 Junovan 51 PMA submission 51 BEMA Fentanyl 51 Fanapt TM 51 Genzyme Quarterly Report 51 orphan designation 51 SANCTURA R 51 BrachySil 51 valuations thereof 51 Programmable Solutions 51 ELEVESS 51 ONSOLIS 51 FDA approvable letter 50 Antitrust Improvement 50 REPLAGAL 50 GEM #S 50 PLIVA dd 50 Approvable Letter 50 IoGen 50 TRANSDUR Sufentanil 50 PD2i Analyzer ™ 50 WILEX 50 Somaxon ability 50 confirmatory Phase 3 49 Abstral 49 CRINONE ® 8 49 SFDA approval 49 European Medicines Evaluation 49 El Quevar project 49 Pennsaid R 49 Market Approval PMA 49 NV Organon 49 requisite regulatory approvals 49 DAVANAT ® 49 SILENOR ™ 49 prGCD 49 * Potentially libelous 49 rhThrombin 49 Rhucin ® 49 FavId 49 confirmatory Phase III 49 Urocidin 49 Application MAA 49 ViaCyte 49 JZP 6 49 voclosporin 49 ATryn ® 49 Marketing Authorization Application 49 Adcirca 49 Complete Response letter 49 Orphan Drug status 49 fourthquarter